cgp 28392 has been researched along with alprostadil in 1 studies
| Studies (cgp 28392) | Trials (cgp 28392) | Recent Studies (post-2010) (cgp 28392) | Studies (alprostadil) | Trials (alprostadil) | Recent Studies (post-2010) (alprostadil) |
|---|---|---|---|---|---|
| 76 | 1 | 2 | 7,136 | 864 | 761 |
| Protein | Taxonomy | cgp 28392 (IC50) | alprostadil (IC50) |
|---|---|---|---|
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | 2.3 | |
| Solute carrier organic anion transporter family member 2B1 | Rattus norvegicus (Norway rat) | 0.0358 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bühler, FR; Erne, P; Resink, TJ | 1 |
1 other study(ies) available for cgp 28392 and alprostadil
| Article | Year |
|---|---|
The influence of CGP 28392, a 1,4-dihydropyridine, on human platelet calcium and cyclic AMP metabolism.
Topics: Alprostadil; Blood Platelets; Calcium; Calcium Channel Blockers; Cyclic AMP; Humans; In Vitro Techniques; Kinetics; Nifedipine; Nitrendipine; Phosphorylation; Protein Kinases; Pyridines | 1985 |